GLP-1 Drugs and Pregnancy: What Every Woman Should Know Before Starting Ozempic or Wegovy

GLP-1 Drugs and Pregnancy Planning: What Every Woman Needs to Know

Millions of women are taking GLP-1 drugs for weight loss or diabetes — but what happens if you want to get pregnant?

GLP-1 medications have changed the conversation around weight loss and metabolic health. But if you are a woman of reproductive age, the story gets more complicated. Here is what the current evidence and medical guidance actually say.

What Are GLP-1 Drugs, and Why Are So Many Women Taking Them?

GLP-1 receptor agonists — including semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (Mounjaro and Zepbound) — work by mimicking a gut hormone that regulates blood sugar, slows digestion, and reduces appetite. They were originally developed to treat type 2 diabetes and have since been approved for chronic weight management.

Use among women of reproductive age has grown sharply. Many women in their 20s, 30s, and 40s are now taking these drugs — sometimes without fully discussing what that means for future pregnancy plans.

What Does the FDA Say About These Drugs and Pregnancy?

The FDA has not approved any GLP-1 drug for use during pregnancy. The prescribing information for semaglutide and tirzepatide includes a warning that these medications should be discontinued before a planned pregnancy.

Animal studies — which are an early but limited form of evidence — have shown potential risks to fetal development at doses comparable to those used in humans. Because human pregnancy data is very limited, the FDA advises that women who are pregnant or planning to become pregnant discuss stopping the medication with their doctor.

The FDA currently recommends discontinuing semaglutide at least two months before a planned pregnancy. Tirzepatide labeling suggests stopping at least one month in advance. These timelines are based on how long the drugs remain active in the body, not on proven safety windows — so the guidance may evolve as more data becomes available.

Here Is Something Unexpected: GLP-1 Drugs May Increase Fertility

Here is a twist many women do not see coming. Research published in the journal Obesity suggests that GLP-1 drugs may improve fertility in women with polycystic ovary syndrome (PCOS), a condition that affects roughly one in ten women of reproductive age and is a common cause of irregular cycles and difficulty conceiving.

By improving insulin sensitivity and promoting weight loss, these medications may help restore more regular ovulation in some women with PCOS. That means a woman who believed she was unlikely to conceive could become pregnant while taking a GLP-1 drug — sometimes without realizing the medication has changed her fertility picture.

This makes contraception planning an essential conversation for any woman of reproductive age who starts one of these drugs. If you are not planning a pregnancy, talk to your doctor about reliable contraception before or when you begin treatment.

What About Women Who Get Pregnant While Still on a GLP-1 Drug?

It happens. Because these drugs are taken weekly and work gradually, some women may not realize they are pregnant until after several weeks of exposure. If you discover you are pregnant while taking a GLP-1 medication, the guidance from medical professionals is clear: contact your doctor promptly. Do not make any changes to your medication on your own.

The FDA maintains a pregnancy exposure registry for semaglutide. Reporting pregnancies that occur during treatment helps build the safety database that researchers and regulators need to give better guidance in the future. Your doctor can walk you through how to participate.

The Weight Loss Rebound Question

One practical concern women raise: stopping a GLP-1 drug before pregnancy often means regaining weight. Research published in the New England Journal of Medicine has shown that most people regain a significant portion of lost weight within a year of stopping semaglutide.

For women who were prescribed these drugs to manage obesity-related health risks, the conversation with their doctor needs to cover what that transition looks like — including whether lifestyle strategies, nutrition support, or other approaches can help maintain metabolic health during pregnancy planning and pregnancy itself.

This is not a reason to avoid stopping the drug if you are planning a pregnancy. It is a reason to plan ahead and work closely with your healthcare team.

What to Ask Your Doctor

If you are a woman of reproductive age taking a GLP-1 drug — or thinking about starting one — these are worth discussing with your physician:

  • When should I stop this medication if I want to try to conceive?
  • What contraception options are right for me while I am on this drug?
  • If I have PCOS, how might this medication affect my fertility?
  • What is the plan for managing my weight or blood sugar during pregnancy if I stop?
  • Are there any registry programs I should know about?

The Bottom Line

GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are powerful tools for managing weight and metabolic health — but they are not recommended during pregnancy, and women of reproductive age need a clear plan before starting them. The good news: with the right conversations and planning, you can protect both your health goals and your pregnancy options. Talk to your doctor before you start, and talk to your doctor before you try to conceive.

Medical Disclaimer: This article is for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional regarding your individual health needs.

ad-image
Copyright © 2026 Feel Amazing Daily - All Rights Reserved
Powered by